Every recall we track for VITRUVIAS THERAPEUTICS INC — 1 in all, all from 2026 — plus the complaints and injury reports the public filed about them. 1 is rated “stop using now”.
1 recall from VITRUVIAS THERAPEUTICS INC are on record with U.S. safety agencies, from 2026.
VITRUVIAS THERAPEUTICS INC recalls Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg,, dated Aug 21, 2026. Every VITRUVIAS THERAPEUTICS INC recall is listed on this page, newest first.
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.
